UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.414

Sortiert nach

Genome-Wide Methylation Study Identifies an IL-13–induced Epigenetic Signature in Asthmatic Airways

American journal of respiratory and critical care medicine, 2016-02, Vol.193 (4), p.376-385

2016

Link zum Volltext

Verfügbarkeit prüfen

Mast cell–derived IL-13 downregulates IL-12 production by skin dendritic cells to inhibit the TH1 cell response to cutaneous antigen exposure

Journal of allergy and clinical immunology, 2021-06, Vol.147 (6), p.2305-2315.e3

2021

Link zum Volltext

Verfügbarkeit prüfen

IL-13 protects from C. difficile colitis

Anaerobe, 2024-08, Vol.88, p.102860, Article 102860

2024

Link zum Volltext

Verfügbarkeit prüfen

Adipose tissue remodeling via TSLP-mediated IL-4/IL-13 signaling: Implications for atopic dermatitis and skin barrier

Journal of allergy and clinical immunology, 2024-06

Sugita, Kazunari

2024

Link zum Volltext

Verfügbarkeit prüfen

Mechanistic insights into the antipruritic effects of lebrikizumab, an anti–IL-13 mAb

Journal of allergy and clinical immunology, 2022-09, Vol.150 (3), p.690-700

2022

Link zum Volltext

Verfügbarkeit prüfen

Thymic stromal lymphopoietin induces IL-4/IL-13 from T cells to promote sebum secretion and adipose loss

Journal of allergy and clinical immunology, 2023-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

Journal of the American Academy of Dermatology, 2020-02, Vol.82 (2), p.377-388

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular Targets for Biological Therapies of Severe Asthma

Frontiers in immunology, 2020-11, Vol.11, p.603312-603312

2020

Link zum Volltext

Verfügbarkeit prüfen

Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis

Allergy (Copenhagen), 2020-01, Vol.75 (1), p.54-62

Bieber, Thomas

2020

Link zum Volltext

Verfügbarkeit prüfen

B Cell Presentation of Chlamydia Antigen Selects Out Protective CD4γ13 T Cells: Implications for Genital Tract Tissue-Resident Memory Lymphocyte Clusters

Infection and immunity, 2018-02, Vol.86 (2)

2018

Link zum Volltext

Verfügbarkeit prüfen

Implications of IL-13Rα2 in atopic skin inflammation

Allergology International, 2020-07, Vol.69 (3), p.412-416

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb

Journal of allergy and clinical immunology, 2019-01, Vol.143 (1), p.135-141

2019

Link zum Volltext

Verfügbarkeit prüfen

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation

Allergy (Copenhagen), 2020-05, Vol.75 (5), p.1188-1204

2020

Link zum Volltext

Verfügbarkeit prüfen

Epithelial cell‐expressed type II IL‐4 receptor mediates eosinophilic esophagitis

Allergy (Copenhagen), 2023-02, Vol.78 (2), p.464-476

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)

Journal of the American Academy of Dermatology, 2018-05, Vol.78 (5), p.863-871.e11

2018

Link zum Volltext

Verfügbarkeit prüfen

Regulation of entheseal IL-23 expression by IL-4 and IL-13 as an explanation for arthropathy development under dupilumab therapy

Rheumatology (Oxford, England), 2021-05, Vol.60 (5), p.2461-2466

2021

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council

Journal of allergy and clinical immunology, 2021-04, Vol.147 (4), p.1174-1190.e1

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of serum interleukin‐13 and interleukin‐13 receptor subunit expressions: Rheumatoid arthritis–associated interstitial lung disease

International journal of rheumatic diseases, 2021-04, Vol.24 (4), p.591-598

2021

Link zum Volltext

Verfügbarkeit prüfen

Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells

Journal of allergy and clinical immunology, 2020-07, Vol.146 (1), p.80-88.e8

2020

Link zum Volltext

Verfügbarkeit prüfen

N -Glycosylation Regulates Chitinase 3-like-1 and IL-13 Ligand Binding to IL-13 Receptor α2

American journal of respiratory cell and molecular biology, 2020-09, Vol.63 (3), p.386-395

2020

Link zum Volltext

Verfügbarkeit prüfen

NOTCH4 potentiates the IL-13 induced genetic program in M2 alternative macrophages through the AP1 and IRF4–JMJD3 axis

International immunology, 2023-10, Vol.35 (10), p.497-509

2023

Link zum Volltext

Verfügbarkeit prüfen

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets

Frontiers in pharmacology, 2022-03, Vol.13, p.851940-851940

2022

Link zum Volltext

Verfügbarkeit prüfen

Foxp3 and Bcl6 deficiency synergistically induces spontaneous development of atopic dermatitis-like skin disease

International immunology, 2023-09, Vol.35 (9), p.423-435

2023

Link zum Volltext

Verfügbarkeit prüfen

Flow cytometric identification of Tfh13 cells in mouse and human

Journal of allergy and clinical immunology, 2021-02, Vol.147 (2), p.470-483

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.414

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.310)
Mit Volltextzugriff
(1.333)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Genome-Wide Methylation Study Identifies an IL-13–induced Epigenetic Signature in Asthmatic Airways

Mast cell–derived IL-13 downregulates IL-12 production by skin dendritic cells to inhibit the TH1 cell response to cutaneous antigen exposure

IL-13 protects from C. difficile colitis

Adipose tissue remodeling via TSLP-mediated IL-4/IL-13 signaling: Implications for atopic dermatitis and skin barrier

Mechanistic insights into the antipruritic effects of lebrikizumab, an anti–IL-13 mAb

Thymic stromal lymphopoietin induces IL-4/IL-13 from T cells to promote sebum secretion and adipose loss

Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

Molecular Targets for Biological Therapies of Severe Asthma

Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis

B Cell Presentation of Chlamydia Antigen Selects Out Protective CD4γ13 T Cells: Implications for Genital Tract Tissue-Resident Memory Lymphocyte Clusters

Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch

Implications of IL-13Rα2 in atopic skin inflammation

Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation

Epithelial cell‐expressed type II IL‐4 receptor mediates eosinophilic esophagitis

Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)

Regulation of entheseal IL-23 expression by IL-4 and IL-13 as an explanation for arthropathy development under dupilumab therapy

Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council

Identification of serum interleukin‐13 and interleukin‐13 receptor subunit expressions: Rheumatoid arthritis–associated interstitial lung disease

Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells

N -Glycosylation Regulates Chitinase 3-like-1 and IL-13 Ligand Binding to IL-13 Receptor α2

NOTCH4 potentiates the IL-13 induced genetic program in M2 alternative macrophages through the AP1 and IRF4–JMJD3 axis

Interleukins 4 and 13 in Asthma: Key Pathophysiologic Cytokines and Druggable Molecular Targets

Foxp3 and Bcl6 deficiency synergistically induces spontaneous development of atopic dermatitis-like skin disease

Flow cytometric identification of Tfh13 cells in mouse and human

Suchergebnisse filtern